These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33162933)

  • 1. Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders.
    Trajanoska K; Rivadeneira F
    Front Endocrinol (Lausanne); 2020; 11():556610. PubMed ID: 33162933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of bone mass and susceptibility to bone diseases.
    Karasik D; Rivadeneira F; Johnson ML
    Nat Rev Rheumatol; 2016 Jun; 12(6):323-34. PubMed ID: 27052486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscellaneous Bone Disorders.
    Mughal MZ; Padidela R
    Endocr Dev; 2015; 28():226-246. PubMed ID: 26138845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of abnormal skeletal development and homeostasis.
    McLean W; Olsen BR
    Trends Genet; 2001 Oct; 17(10):S38-43. PubMed ID: 11585675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis.
    Robinson MK; Caminis J; Brunkow ME
    Drug Discov Today; 2013 Jul; 18(13-14):637-43. PubMed ID: 23579167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.
    Fijalkowski I; Boudin E; Mortier G; Van Hul W
    Curr Osteoporos Rep; 2014 Sep; 12(3):243-51. PubMed ID: 24947952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Genetics of Sclerosing Bone Disorders.
    De Ridder R; Boudin E; Mortier G; Van Hul W
    Curr Osteoporos Rep; 2018 Jun; 16(3):256-268. PubMed ID: 29656376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
    Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
    Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis.
    El-Gazzar A; Högler W
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in bone dysplasias.
    Spranger J
    Prog Clin Biol Res; 1982; 103 Pt B():323-32. PubMed ID: 7163228
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic disorders and bone affecting the craniofacial skeleton.
    Chacon GE; Ugalde CM; Jabero MF
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):467-74, v. PubMed ID: 18088898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.
    Mäkitie RE; Kämpe AJ; Taylan F; Mäkitie O
    Curr Osteoporos Rep; 2017 Aug; 15(4):303-310. PubMed ID: 28646443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin and skeletal health.
    Sharifi M; Ereifej L; Lewiecki EM
    Rev Endocr Metab Disord; 2015 Jun; 16(2):149-56. PubMed ID: 25669441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing for disorders of low and high bone mineral density.
    Sule G; Campeau PM; Zhang VW; Nagamani SC; Dawson BC; Grover M; Bacino CA; Sutton VR; Brunetti-Pierri N; Lu JT; Lemire E; Gibbs RA; Cohn DH; Cui H; Wong LJ; Lee BH
    Osteoporos Int; 2013 Aug; 24(8):2253-9. PubMed ID: 23443412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life span care for patients with skeletal dysplasia: A roadmap.
    Nijhuis WH; Verhoef M; Sakkers RJB
    Eur J Med Genet; 2023 Nov; 66(11):104851. PubMed ID: 37758161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Osteoporosis in Children.
    van Dijk FS
    Endocr Dev; 2015; 28():196-209. PubMed ID: 26138843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaphyseal dysplasia, epiphyseal dysplasia, diaphyseal dysplasia, and related conditions. I. Familial metaphyseal dysplasia and craniometaphyseal dysplasia; their relation to leontiasis ossea and osteopetrosis; disorders of bone remodeling.
    JACKSON WP; ALBRIGHT F; DREWRY G; HANELIN J; RUBIN MI
    AMA Arch Intern Med; 1954 Dec; 94(6):871-85. PubMed ID: 13217486
    [No Abstract]   [Full Text] [Related]  

  • 18. Collagen, genes and the skeletal dysplasias on the edge of a new era: a review and update.
    Lachman RS; Tiller GE; Graham JM; Rimoin DL
    Eur J Radiol; 1992; 14(1):1-10. PubMed ID: 1563395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathophysiology of osteoporosis/osteopenia in gene mutant mice].
    Kobayashi Y; Takahashi N
    Clin Calcium; 2006 Feb; 16(2):311-18. PubMed ID: 16465035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Architecture of High Bone Mass.
    Gregson CL; Duncan EL
    Front Endocrinol (Lausanne); 2020; 11():595653. PubMed ID: 33193107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.